Compositions and methods for enhancing contrast in imaging

Details for Australian Patent Application No. 2005239980 (hide)

International Classifications

Event Publications

9 November 2006 PCT application entered the National Phase

PCT publication WO2005/107820 Priority application(s): WO2005/107820

10 December 2009 Assignment before Grant

Marvel Therapeutics The application has been assigned to Marvel BioSciences, Inc.

25 February 2010 Application Accepted

Published as AU-B-2005239980

4 March 2010 Corrigenda

Assignments Before Grant, Section 113 - 2005 Under the name Marvel Therapeutics, Application No. 2005239980 under INID (71) correct the name to read Marval BioSciences, Inc.

24 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.